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“Few procedures provide the urologist with more 
satisfaction than those that preserve renal function” 
(Benjamin Abeshouse, 1950) 
 
 
 
 
 
 
 
 
 
 
 
If we want to see into the future, we need only look to the 
past 
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1. INTRODUCTION 
 
1.1. THE CHANGING FACE OF RENAL CELL CARCINOMA  
 
1.1.1. Epidemiology of renal cell cancer.  
 
Renal cell carcinoma (RCC) makes up approximately 2-3% of all cancers and 
accounts for 90% of all malignancies of the kidney. It is the 9
th
 most common cancer 
in men and 14
th
 in women. However, the incidence of RCC varies worldwide (Ferlay 
J et al. 2012)
1
. It is more common in industrialized countries where it is ranked in 
both sexes as 11
th
 most common tumor while in developing countries it is ranked as 
21
st
 place. Although the male-to-female ratio differs significantly for each type of 
renal cell tumor and in different age groups, generally there is a 2:1 predominance of 
men over women, with peak incidence occurring between 60 and 70 years of age 
(Hew MN et al. 2012)
2
. 
Through the past decades there has been a steady increase in number of clinically 
recognized RCC in industrialized countries.  
The growing number of incidentally detected RCC cannot be explained exclusively 
by extensive use of modern imaging techniques. Several other factors related to life 
style of modern industrialized countries may also play a role in the increasing rate of 
RCC. The exact etiology of RCC, with exception of hereditary cases, is still 
unknown. It is estimated that smoking accounts for around one third of the RCC 
cases (Cumberbatch MG et al. 2016)
3
. In addition to smoking, which doubles the 
risk for RCC, obesity, hypertension and an unhealthy diet are also associated with 
the tumor development (Chow W-H et al. 2010)
4
.  
Through the past decades the mortality rate has stabilized or even declined in most 
European countries.  
In spite of the increasing number of clinically detected RCC, the mortality rate due 
to RCC has stabilized or even declined in European countries and the USA (Levi et 
al. 2008)
5
. The widespread use of imaging technique resulted in the detection of 
RCC that are smaller and of lower stage (Lightfoot et al. 2000)
6
. The number of 
incidentally detected T1a and also T1b tumours is increasing in operation statistics 
of most urological centers. These tumours metastasize less often compared with 
higher stage tumours.  
 6 
1.1.2. New genetic classification system  
 
RCC is not considered as a single pathological entity, but different types 
characterized by specific genetic alteration and natural history (Kovacs, 1993)
7
. The 
new knowledge was discussed at a conference held in Heidelberg and published as 
the Heidelberg Classification of Renal Cell Tumors (Kovacs et al. 1997)
8
. Each type 
of tumour displays a combination of chromosomal-genomic alterations of diagnostic 
impact (Table 1). The new classification system is now adapted by the WHO. The 
diagnosis of a specific type of RCC itself has a strong impact on the prognosis of 
tumors as the 5 years tumour specific survival indicates (Table 1).  
 
Table 1. Some pertinent genetic data on distinct types of renal cell tumours. 
Tumor Frequency 
(%) 
Genomic alterations* Gene mutations 5 years 
survival (%) 
cRCC 65-70 -3p, +5q, -6q, -8p, -9p, -14q VHL (50%) 
PBRM1 (35%) 
~60 
pRCC 10-15 +7, +17, +8, +12, +16, +20,  MET (5%) ~90 
chRCC 5-7 -1, -2, -6, -10, -13, -17, -21 p53 (25%) ~95 
RO 5-7 -1, -14q or t(11q:?) or none ? 100 
ucRCC 5-7 ? ? ~20 
CDC <1 ? ? 30 
MTSCC <1 -1, -4, -6, -9, -13, -14, -15, -
22 
? 100 
MA <1 none ? 100 
cRCC-conventional RCC, pRCC-papillary RCC, chRCC-chromophobe RCC, RO-
renal oncocytoma, ucRCC-unclassified RCC, CDC-collecting duct carcinoma, 
MTSCC-mucinous tubular and spindle cell carcinoma, MA-metanephric adenoma. 
*Genomic alterations: „-„ = loss, „+” = gain, t = translocation; VHL – von Hippel 
Lindau gene; MET – Met tyrosin kinase receptor. (Table 1. is kindly provided by 
Professor Gyula Kovacs). 
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Based on the characteristic cell morphology and growth pattern, 4 main types of 
renal cell tumours can be distinguished (Figure 1). The most common conventional 
RCC (also called clear cell RCC, which is a misleading name as every fourth of this 
genetically defined tumour does not display clear but eosinophilic cytoplasm). In 
spite of overlapping phenotype, the histological diagnosis can be made by 
experienced pathologist on haematoxilin-eosin stained slides in the vast majority of 
cases. However, in some cases a genetic analysis is necessary to detect the tumour 
type specific alterations and to achive a correct diagnosis, especially for the 
differential diagnosis  of benign renal oncocytoma and malignant chromophobe 
RCC (Table 1). 
                
      
Figure 1. Characteristic histological picture of four main types of renal cell 
tumours. A, Conventional RCC composed of trabecular arranged clear cells with 
empty cytoplasm and picnotic nuclei. B, Papillary renal cell carcinoma composed of 
medium sized eosinophilic cells with foamy cells in papillary stalks. C, 
Chromophobe renal cell carcinoma with large pale cells, double nuclei arranged in 
large epithelial sheets. D, Renal oncocytoma showing large nests of strong 
eosinophilic cells embedded in oedematous stroma. (Haematoxylin and eosin 
staining, x400) (Kindly provided by Professzor Gyula Kovacs) 
A 
D C 
B 
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1.1.3. TNM-G Classification and Staging: Estimating the outcome of the disease  
 
In 2012, 84.000 patients were diagnosed with renal cell carcinoma (RCC) and 
35,000 patients died due to disease in European countries (Ferlay et al. 2013)
9
. 
Mortality of RCC correlates directly with the presence or postoperative development 
of metastasis. Approximately 20-25% of the most common conventional RCC are 
presented with advanced disease at the time of diagnosis and further 15-20% will 
develop metastasis within the next 5 years (Zisman et al. 2002)
10
.  
When diagnosing cancer, the TNM Classification and stage of the tumor are 
important parameters which direct the management and used to estimate the 
outcome of disease (Table 2). The cancer specific survival rate is much higher in a 
cohort of patients with lower stage of RCC. There is a good correlation between the 
size of tumour and progression of disease. The latest classification divided T1 
tumours into subgroup ≤ 4 cm (T1a) and another one > 4 cm and ≤ 7 cm in diameter 
(T1b), the former having a better prognosis. Moreover, T2 tumours have also been 
divided into two classes: T2a are tumours with a size > 7 and ≤ 10 cm, and T2b 
tumours > 10 cm, but confined to the kidney. This classification may be crucial by 
decision of carrying out a partial nephrectomy. The regional lymph node (N) 
positivity is another parameter having an influence on the outcome of the disease. 
The new classification system uses only one class. e.g. metastasis in one or more 
lymph nodes. The metastasis (M) is the ultimate sign of tumour malinancy, leading 
to patients’ death in the overwhelming majority of cases in spite of modern targeted 
therapy. 
Nuclear grading refers to the appearance of the cancer cells under the microscope. 
The grade indicates how the cancer may behave, and is one of the important 
prognostic factor of RCC. The four grade nuclear grading system is the most used 
grading system for kidney cancer. However, recent studies showed by follow-up 
studies, that patients with grade 1 and grade 2 tumours have a similar survival and 
therefore can be evaluated together as a single grade. Doing so will result in the 
three grade system with better estimation of the outcome of the disease.  
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 Table 2. TNM Classification of kidney cancers  
T: Primary tumour 
Tx Primary tumour cannot be assessed 
T0 No evidence of primary tumour 
T1 Tumour ≤ 7 cm in greatest dimension, limited to the kidney  
T1a Tumour ≤ 4 cm in greatest dimension, limited to the kidney  
T1b Tumour > 4 cm but ≤ 7 cm in greatest dimension  
T2 Tumour > 7 cm in greatest dimension, limited to the kidney 
T2a Tumour > 7 cm but ≤ 10 cm in greatest dimension 
T2b Tumours > 10 cm limited to the kidney 
T3 
Tumour extends into major veins or perinephric tissues but not into the 
ipsilateral adrenal gland or beyond Gerota’s fascia 
T3a 
Tumour grossly extends into the renal vein or its segmental (muscle-containing) 
branches, or invades perirenal and/or renal sinus fat (peripelvic), but not into the 
adrenal gland and not beyond Gerota’s fascia 
T3b Tumour grossly extends into the vena cava (VC) below the diaphragm 
T3c 
Tumour grossly extends into vena cava above the diaphragm or invades the wall 
of the VC 
T4 
Tumour invades beyond Gerota’s fascia (including contiguous extension into 
the ipsilateral adrenal gland) 
N: Regional lymph nodes 
NX  Regional LNs cannot be assessed  
N0  No regional LN metastasis  
N1 Regional LN metastasis  
M: Distant metastasis 
M0 No distant metastasis 
M1 Distant metastasis 
 
The results of TNM classification are grouped to determine the patient’s overall 
survival changes (Table 3). The four tumor stages (Stage I-IV) are a combination of 
local growth of tumor without or with invasive growth, the lymph node involvement 
and distant metastasis. The vast majority of tumors in Stage I and II have a high 
cancer specific survival, whereas stage IV tumors are in most cases fatal.  
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 Table 3. TNM stage grouping of kidney cancer  
Stage I  T1               N0           M0 
Stage II. T2               N0           M0 
Stage III.  
T3               N0           M0 
T1,T2,T3    N1           M0 
Stage IV. 
T4               Any N     M0 
AnyT          AnyN      M1 
 
Stage I tumours are the best candidates for laparoscopic partial nephrectomy (LPN), 
but larger tumours confined to the kidney (Stage II) may also be removed by 
laparoscopic radical nephrectomy (LRN). From the technical point of view, another 
scoring system, the PADUA score, is more important for a laparoscopic urologist. 
 
1.1.4.  Anatomic classification system: The PADUA and RENAL nephrometry 
scores 
 
Because of the widespread use of imaging techniques such as ultrasonography and 
computed tomography, a large number of small localized renal cell tumours are 
detected incidentally. The vast majority of incidentally detected tumours are pT1a or 
pT1b and confined to the kidney, e.g. Stage I or Stage II tumours. For such patients, 
organ-sparing surgery is considered as the standard of care if applicable. There is no 
difference regarding tumour recurrence and cancer specific survival of patients with 
small renal tumours operated with open or laparoscopic radical or partial 
nephrectomy. Therefore, for decision making of the operation technique other 
parameters are necessary. 
 
Objective anatomical classification systems, such as the Preoperative Aspects and 
Dimensions Used for an Anatomical (PADUA) classification system, and the 
Radius (tumor size as maximal diameter), Exophytic/endophytic properties of the 
tumor, Nearness of tumor deepest portion to the collecting system or sinus, 
Anterior/posterior descriptor and the Location relative to the polar line (R.E.N.A.L.) 
nephrometry score and the C-index have been proposed, to standardise the 
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description of renal tumours (Figure 2) (Kutikov and Uzzo, 2009)
11
. These systems 
are helpful as it allows objective prediction of potential morbidity of NSS and 
tumour ablation techniques. These tools provide information for treatment planning, 
patient counselling, and comparison of partial nephrectomy (PN) and tumour 
ablation series. However, when selecting the best treatment option, anatomic scores 
must always be considered together with patient features and surgeon experience. 
 
 
 
Figure 2. R.E.N.A.L. Nephrometry Score with scoring of (L)ocation component. 
Polar lines (solid lines) and axial renal midline (broken line) are depicted on each 
sagittal view of kidney. Numbers 1 to 3 represent points attributed to each category 
of tumor (Kutikov and Uzzo, 2009) 
 
 12 
The PADUA score is an important tool to predict possible risk of complications and 
the length of ischemia time. It is important for selection of patients for open, 
laparoscopic or robotic-assisted approaches. The size of tumour is one of the 
important parameters for the choice of surgical treatment, e.g. partial or radical 
nephrectomy. Small pT1a tumours are good candidates for NSS. However, in 
selected patients larger tumours can be removed by partial nephrectomy applying 
either open or laparoscopic surgery. Another important parameter of the scoring 
system is the tumour location. The localisation of tumour within the kidney plays a 
crucial role in the decision of the surgical treatment. Polar, rim or central location, 
the relationship with renal sinus and collecting duct system, the deep position are 
important parameters in the decision of total or partial nephrectomy. The 
preoperative PADUA score is an independent predictor of the occurrence of 
postoperative complications. A PADUA score of 10 or 8-9 means an approximately 
30 and 15 fold risk for postoperative complications compared to PADUA score 6-7 
which are reference scores of harad ratio (Figure 3) (Ficarra et al. 2009)
12   
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Figure 3. (a) Longitudinal classification of the tumours; (b) margin location of the 
tumours; (c) tumour relationship with renal sinus; (d) tumour relationship with 
urinary collecting system; (e) tumour deepening into the parenchyma; (f) tumour 
size classification. 
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1.2. OPEN OR LAPAROSCOPIC SURGERY FOR TREATMENT OF 
KIDNEY CANCER  
 
Surgery remains the only curative treatment for RCC. The objective of surgical 
therapy is to excise the entire tumour with an adequate surgical margin. In 1969, 
Robson and colleagues
13
 established radical nephrectomy (RN) as the “gold 
standard” curative operation for localized RCC. In the past three decades, the 
increased use of imaging modalities such as ultrasound (US) and computerized 
tomography (CT) has led to increase the number of incidentally detected renal 
masses
6
. Tumours detected by imaging techniques tend to be smaller, lower stage 
lesions that are typically amenable to partial nephrectomy (PN). The main aim of 
this surgical procedure is maximal preservation of unaffected renal parenchyma 
without sacrificing cancer control. During the last several years, refinements in the 
surgical technique of PN have made this procedure technically safe with acceptable 
complication rates. Long-term outcome data indicate that open partial nephrectomy 
(OPN) has cancer-free survival rates comparable to those of radical surgery with 
better preservation of renal function (RF), reduced frequency of cardiovascular 
events, and decreased overall mortality rate (Margreiter and Marbereger, 2010)
14
. 
 According to European Association of Urology (EAU) guidelines 2016, with 
grade of recommendation “A”, for T1a tumours, NSS is recommended and for T1b 
tumours, NSS should be favoured over RN whenever feasible. RN is no longer the 
gold standard treatment in these cases (Delakas et al. 2002)
15
. Standard indications 
for NSS are divided into the following categories: 1). Absolute – anatomical or 
functional solitary kidney, and bilateral renal tumours. 2). Relative – functioning 
opposite kidney is affected by a condition that might impair RF in the future, e.g.: 
hereditary forms of RCC, diabetes mellitus, hypertension, autoimmune diseases, 
stone formers, etc. 3). Elective – localized unilateral RCC with a healthy 
contralateral kidney. Recently, cases of elective indications for NSS of RCC have 
vastly increased. It has been proved that, in these cases, NSS for tumours limited in 
diameter to 4 cm (pT1a) provides recurrence-free and long-term survival rates 
similar to those observed after radical surgery (Becker et al. 2006)
16
. For larger 
tumours (pT1b), PN has demonstrated feasibility and oncological safety in carefully 
selected patients (Patard et al. 2004)
17
.  
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The impact of laparoscopy has increased rapidly within the last two decades, and as 
a result, laparoscopic radical nephrectomy has become a recognized standard 
surgical approach by the 2006 European Association of Urology guidelines. Parallel 
to this evolution in technique, the indication for radical nephrectomy has also 
changed to a great extent. By means of imaging techniques such as ultrasonography 
and computed tomography scanning, an increasing number of small renal cancers 
are being detected incidentally. For the majority of these tumors nephrectomy is an 
over-treatment, and NSS has to be considered instead even if there is a normally 
functioning contralateral kidney because oncologic results are as good as with 
radical nephrectomy. Many surgeons are now confronted with the difficult situation 
that they can offer radical nephrectomy by means of laparoscopy to remove large 
tumors but are unable to perform laparoscopic NSS for the small ones. Thus, great 
effort has been directed towards the development of reliable and reproducible 
techniques for laparoscopic partial nephrectomy (LPN). 
 
Open surgical partial nephrectomy is usually performed in ischemia to allow for 
precise tumor excision and reconstruction of the renal parenchyma in a bloodless 
field. Gill (Gill et al. 2002)
18
 was the first to show that these principles of open 
surgery can be duplicated by means of laparoscopy. Ischemia time, however, is 
critical for renal function which is traditionally restricted to a maximum of 
30 minutes. Ischemia time can be increased substantially by cooling of the renal 
parenchyma, which is easily induced during open surgery. When comparing 
laparoscopy with open surgery, ischemia time is longer even in the most experienced 
hands and hypothermia for protection of the renal function is difficult to achieve. 
 
Several attempts have been made to overcome the aforementioned problems in 
laparoscopic approaches. Direct excision of small and peripherally located tumors is 
feasible without ischemia. Haemostasis can be achieved by bipolar coagulation, 
ultrasonic scalpel, radiofrequency, microwave tissue coagulator and several other 
devices. A variety of tissue sealants have also been used for this purpose. The main 
problem with these techniques is not the haemostasis; however, because of ongoing 
burning and charring of the tissues and continuing bleeding, it becomes impossible 
to distinguish between normal parenchyma and tumor tissue so that a positive 
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surgical margin cannot be realized anymore. Therefore, this technique can be 
recommended for highly selected cases only. 
 
Several technical modifications of laparoscopic partial nephrectomy have resulted in 
a substantial reduction of the time required for haemostasis and reconstruction of the 
parenchyma. Knotting is the most time-consuming part of laparoscopic 
reconstructive procedures. Therefore, all knots are replaced by clips. The large clips 
(Hem-o-lok
®
) used for the approximation of the parenchyma have the additional 
advantage that they avoid the suture cutting through the parenchyma when pressure 
is applied. Thereby efficient haemostasis can be achieved. 
 
1.3. LAPAROSCOPIC SURGERY FOR TREATMENT OF T1 KIDNEY 
CANCER  
 
Minimal invasive surgery, owing to its lower morbidity comparing to open surgery, 
has reformed urologic surgical approach particularly in kidney surgery. Since its 
introduction in 1990 by Clayman and colleagues (Clayman et al. 1991)
19
, 
laparoscopic nephrectomy (LN) for RCC has become an established surgical 
procedure worldwide. Whether done retro-peritoneally or trans-peritoneally, the 
laparoscopic approach must follow established open surgical oncological principles. 
Long-term outcome data indicate that LRN has equivalent cancer-free survival rates 
to those of open radical nephrectomy (Hemal et al. 2007)
20
. Consequently, LRN has 
become the standard of care for patients with T1 and T2 renal masses not treatable 
by NSS (Burgess et al. 2007; Rosoff et al. 2009)
21-22
. 
Since the first laparoscopic partial nephrectomy (LPN) performed in 1992 by 
Winfield and colleagues (Winfield et al. 1993)
23
, in experienced hands and selected 
patients, it has become an alternative to open partial nephrectomy (OPN). Generally, 
during LPN, the renal ischemia time is longer than with OPN. Laparoscopic NSS 
has a higher complication rate compared to open surgery. However, the oncological 
outcome in available series with limited follow-up appears to be similar to the 
outcome achieved with open nephron sparing surgery (Gill et al. 2007; Porpiglia et 
al 2008)
24-25
. The optimal indication for laparoscopic nephron sparing surgery is a 
relatively small and peripheral renal tumour. With the ongoing advancements in 
minimal invasive surgery for renal tumours, it is now feasible to perform LPN for 
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larger and more complicated renal masses in experienced centres (Albqami et al. 
2005; Porpiglia et al. 2010)
26-27
. 
 
According to EAU guideline (2010), OPN was considered as the standard of care for 
NSS and LPN was recommended to be performed by experienced surgeons. In EAU 
guidelines (2016), with level of evidence “2b”, it has been modified as follow: PN 
can be performed, either with an open, pure laparoscopic- or robot-assisted 
approach, based on surgeon’s expertise and skills. As familiarity with laparoscopic 
technique has grown in many centres, LPN application has also expanded 
worldwide. Modifications to standard techniques have helped improve perioperative 
characteristics and parameters, to levels comparable to open surgery (Eisenberg et al 
2010)
28
. However, LPN has many technical difficulties when comparing with OPN. 
This is reflected in the learning curve. Operation of approximately 25 cases is 
necessary for OPN whereas to achieve a good experience in LPN around 200 
operations should be carried out (Porpiglia et al. 2008)
25
.  
 
Partial nephrectomy (PN) of either open or laparoscopic access can be divided into 
two main categories: PN without ischemia and PN with ischemia. The former is 
applicable in only selected cases of small peripheral tumors or with application of 
distinctive instrumentations for haemostasis (Knudsen et al. 2010; Thompson et al. 
2010)
29-30
. Bloodless surgical field for optimal tumor excision can only be achieved 
by establishing renal ischemia, which can be applied by either cold ischemia or 
warm ischemia (WI). Renal ischemia can be global when the artery or the whole 
pedicle is clamped or regional when renal parenchymal compression is used. Cold 
ischemia is applied in cases where longer ischemic time is expected. Due to its 
safety and easiness of application, global renal WI is most widely used in most 
partial nephrectomies.  
 
The interest in laparoscopic partial nephrectomy resulted in an urgent need for clear 
data describing ischemic renal damage in relation to time. Exact evaluation of the 
function of the operated kidney must be the basis of every study on that topic. This 
statement sounds very simple. However, when studying the literature on that topic 
one has to realize very quickly that not even this basic question has been answered 
so far. How to evaluate unilateral renal function? Split renal function determined by 
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mercapto-acetyltriglycine (MAG 3) isotope clearance is the minimal requirement. 
However, it cannot distinguish between loss of renal parenchymal volume due to 
excision of healthy tissue together with the tumor and permanent ischemic damage 
of the remaining tissue. Complete excision of a large tumor will result in a decrease 
of the split renal function of the involved kidney. Therefore, additional parameters 
are required to identify ischemic damage of the remaining tissue. Correlation of split 
renal function with the volume of the kidney could solve the problem.  
 
 
1.4. THE EFFECT OF INTRAOPERATIVE ISCHEMIA ON KIDNEY 
FUNCTION 
 
1.4.1. Mechanism of ischemia-reperfusion injury 
 
During renal ischemia, hypoxia caused by cessation of renal blood flow, and finally 
reperfusion caused by instant release of blood flow, trigger a complex series of 
events that lead to tissue injury and acute tubular necrosis. The essential feature of 
injury caused by ischemia and reperfusion (IR) is that the initial damage caused by 
the ischemic insult is exacerbated by the reintroduction of blood flow to the relevant 
area (Wein et al. 2007)
31
. The sentinel biochemical event in renal ischemia is the 
depletion of adenosine triphosphate (ATP), which is the major energy currency for 
cellular work. ATP is metabolized to adenosine monophosphate (AMP). During 
prolonged oxygen deprivation, AMP is further metabolized to the nucleosides 
adenosine, inosine, and hypoxanthine. These compounds diffuse from the cell, 
resulting in the loss of the substrate reservoir for ATP synthesis after reperfusion. 
Furthermore, hypoxanthine becomes an important substrate in the development of 
oxygen free radicals during the reperfusion period (Wein et al. 2007)
31
. At the time 
of reperfusion, xanthine oxidase plays a role in conversion of hypoxanthine to 
xanthine. Xanthine is the major source of superoxide radical, which is ultimately 
metabolized to hydrogen peroxide and hydroxyl radical that produce cellular injury.  
 
This reaction takes about 30 minutes in the kidney (McCord ,1985)
32
.  
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During prolonged ischemia, medullary hypoxia intensifies. Due to the high 
metabolic requirement of the nephron structures located in the outer medulla are 
most sensitive to injury. The straight portion of the proximal tubule sustains the most 
severe injury. Other structures that sustain injury in this region include the medullary 
thick ascending limb. 
 
The arterial occlusion during surgery leads to a localized reduction in renal blood 
flow which disproportionally decreased in the outer medulla due to arteriolar 
vasoconstriction and local edema. IR leads to swelling of endothelial cells and 
enhanced leukocyte-endothelium interaction and some leukocytes migrate into the 
interstitial compartment. In rodent, endothelial cells loss their barrier function within 
two hours after reperfusion. The early innate and also later the adaptive immune 
responses contribute to the pathology of ischemic injury. During the early innate 
response neutrophils, macrophages, natural killer cells accumulate at the ischemic 
site and are active during the first days. 
 
The reduced oxygen and nutrient delivery results in damage of epithelial cells 
especially in the pars recta of proximal tubules, which cannot convert from oxidative 
to glycolytic metabolism. Proximal tubular cells express toll-like receptors (TLR) 
such as TLR2 and TLR4, which initiates proinflammatory response by releasing 
cytokines and chemokines. Thus proximal tubular cells are not only victim the injury 
but actively participate in the inflammatory response to IR damage of the kidney. 
Kidney injury molecule-1 (KIM-1), a marker of proximal tubules injury accumulates 
in the urine after ischemia indication a strong proximal tubules injury (Han et al. 
2002)
33
. Acute kidney injury also activates other genes including the neutrophil 
gelatinase-associated lipocalin (NGAL) (Mishra et al. 2005)
34
. Appearance of both 
genes in the urine indicates a significant injury of proximal tubules. 
 
Cells of the distal tubules are more resistant to hypoxia, oxidative injury, e.g. 
ischemia-reperfusion. Cells of the distal nephron have greater capacity to shift from 
oxidative to glycolytic metabolism during reduced oxygen supply. These cells 
produce more anti apoptotic BCL-2 and also reparative growth factors than proximal 
tubules and therefore minimize the cell death and ischemic injury (Gobe et al. 
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2007)
35
. Crosstalk between distal tubular cells and proximal tubules may contribute 
to the repair of the latter. 
 
The interplay of these abnormalities forms the basis for the acute decrease in 
glomerular filtration rate (GFR), which is the result of intrarenal vasoconstriction, 
with a decrease in glomerular filtration pressure, tubular obstruction, transtubular 
back leakage of the filtrate, and interstitial inflammation (Lameire and Vanholder, 
2001)
36
. Sublethal injury to tubular cells leads to irregularities in the cytoskeletal 
organization of the tubule cells. After sublethal injury, the kidney has a remarkable 
capacity for repair of normal structure and function. 
 
1.4.2. Repair of the tubular system 
 
The kidney can completely recover from short lasting (<30 minutes) ischemia.  
 
Under normal circumstances human proximal tubular cells undergo a slow 
regeneration replacing some damaged cells (Nadasdy et al. 1994)
37
. The low rate of 
cell death and replacement by mitotic tubular cells dramatically changes after 
ischemia-reperfusion injury. Several cells loss the brush border and also the cell 
polarity, undergo necrosis and apoptosis and cause luminal obstruction. Viable cells 
with migration and stem cell like capacity replace the damaged cells, differentiate 
into polarized epithelial cells and finish the regeneration (Figure 4). During this time 
there is an increased mitotic activity in the kidney. 
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Figure. 4. Normal repair in ischemic acute kidney insufficiency. The current 
understanding of tubular injury and repair after ischemic acute kidney injury (AKI). 
With IR injury, the normally highly polar epithelial cell loses its polarity and brush 
border with proteins mislocated on the cell membrane. With increasing time/severity 
of ischemia, there is cell death by either necrosis or apoptosis. Some of the necrotic 
debris is released into the lumen. Viable epithelial cells migrate and cover denuded 
areas of the basement membrane. These cells undergo division and replace lost 
cells. Ultimately, the cells go on to differentiate and reestablish the normal polarity 
of the epithelium (from Yang et al. 2010)
38
. 
 
 In conclusion, the kidney parenchyma has an enormous capacity for repair if the 
ischemic time remains below a limited time. This time frame should be kept in 
mind when carrying out open or laparoscopic partial nephrectomy. 
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2. AIM OF THE STUDY 
 
1. To learn the upper urinary tract laparoscopy from international leading 
urologists in the field, to overcome the learning phase and develop modifications of 
standard laparoscopic techniques. 
 
2. To design a study to answer some challenging questions in relation to the 
impairment of renal function after partial nephrectomy:  
 
a. What is the minimal renal ischemia time which can lead to kidney damage?  
b. What is the maximum ischemia time which can be tolerated by the majority of 
kidneys? 
c. Are there other factors which may worsen the damage?  
d. Are there renoprotective substances which can prolong ischemia time?  
e. What is the impact of volume reduction on renal function outcome after partial 
nephrectomy? 
 
In line with these questions, in patients with small renal mass (pT1a) operated 
with laparoscopic partial nephrectom under warm ischemia, for determination of 
functional outcome, we designed a prospective randomized study to identify the 
role of renal parenchymal volume reduction distinguished from the ischemia-
reperfusion injury. 
 
 
3. OPERATIVE TECHNIQUES AND POSTOPERATIVE FUNCTIONAL 
EVALUATIONS 
 
3.1. LAPAROSCOPIC PARTIAL NEPHRECTOMY IN COLD ISCHEMIA  
 
3.1.1. Background 
 
Within a short period of time, laparoscopic radical nephrectomy for renal cell 
carcinoma (RCC) became a standard of care (Chan et al. 2001)
39
. Because of the 
widespread use of imaging techniques such as ultrasonography and computed 
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tomography (CT), however, a large number of small localized renal tumors are 
detected incidentally (Lightfoot et al. 2000)
6
. For such patients, organ-sparing 
surgery has to be considered as an alternative to radical nephrectomy even if the 
contralateral kidney functions normally (Herr, 1999)
40
. In 2000, it was concluded by 
Fergany et al
41
 that, owing to the encouraging reports about the tumor recurrence 
and cancer specific survival in cases of NSS, it’s not unlikely that partial 
nephrectomy may become more frequent than radical nephrectomy in the future. The 
first laparoscopic partial nephrectomy on a porcine model was reported in 1993 
(McDougal et al. 1998)
42
. Many centers have since developed their techniques to 
perform nephron sparing surgery by means of laparoscopy.  
 
Günter Janetschek was one of the pioneers in performing and developing the 
techniques of wedge resection for RCC by means of laparoscopy about two decades 
ago (Janetschek et al. 1998)
43
. However this technique was restricted to tumors 2 cm 
or less as it was performed without renal ischemia. To duplicate all principles of 
open surgery by means of laparoscopy, the technique was changed by introducing 
renal ischemia and suture repair of the collecting system and renal parenchyma as 
was described by Gill and colleagues (Gill et al. 2002)
18
. Ischemia can be achieved 
by temporary occluding the renal artery or artery and vein (en-bloc), the so-called 
warm ischemia. The time available to do wedge resection and repair of collecting 
system and parenchyma during warm ischemia is limited and the surgeon has to race 
against the clock. Renal cooling during ischemia protects the kidney and offers the 
surgeon extra time. The problem of renal cooling during ischemia when performing 
laparoscopic wedge resection has not been solved yet. In 2003, we presented our 
first experience with renal cooling during laparoscopic surgery for small RCC by 
means of cold arterial perfusion. 
 
3.1.2. Patients and laparoscopic approach 
 
Between November 2001 and March 2003, laparoscopic partial nephrectomy in cold 
ischemia was performed in 17 patients. During this period, no open NSS was done. 
The indication was suspected RCC in 15 patients with a mean tumor size of 2.71 cm 
(range: 1.5 - 4 cm), and a pyelonephretic lower pole due to recurrent stone disease in 
2 patients. The metastatic work up was negative and all tumors were clinically T1a, 
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N0, M0. In all patients, preoperative angio-MRI was performed to visualize the renal 
artery(s). Preoperative renal scintigraphy (DMSA) was done to have a baseline data 
about the renal function for follow-up. Patients were consented for conversion to 
laparoscopic radical nephrectomy or open partial nephrectomy if needed.  
 
Preoperative preparation and anesthesia induction were done as usual. Placement of 
an open tip ureteric catheter (usually a single pigtail catheter) was done under 
fluoroscopy to be used later to check the integrity of the collecting system. Next, an 
angiocatheter was passed into the main renal artery through a femoral puncture on 
the ipsilateral side. This procedure was carried out by one of our interventional 
radiologists. Then the patient was brought to 45-degree lateral decubitus position. In 
this final position for laparoscopic surgery the angiocatheter was checked again and 
advanced in the renal artery close to the origin of the segmental arteries if needed. 
Port placement varied according to the tumor location. 
 
The approach to the kidney was transperitoneal in 16 patients and retroperitoneal in 
1 patient. In the first 2 patients the renal hilum was not dissected, and the renal artery 
was occluded by a balloon integrated in the angiocatheter. However, since some 
arterial bleeding occurred in the second patient, we shifted to use a tourniquet for 
artery occlusion in the following 15 patients, which proved to be much safer. The 
renal artery was secured and later on occluded using a tourniquet (5mm umbilical 
tape and 10 Fr. silicon tube), which was placed as close to the origin of the artery as 
possible. This tourniquet was handled through a separate 10 mm trocar in the lower 
abdomen. We were prepared to occlude additional smaller arteries with laparoscopic 
bulldog clamps, but this was never required. The renal vein was secured (distal to 
the gonadal, lumbar and adrenal veins) but not occluded in 13 patients, using also 
the umbilical tape. We stopped securing the renal vein as we found it was never 
necessary. 
 
Intravenous infusion of 200 cc of 20% mannitol was given 15 minutes before arterial 
occlusion. After approaching the tumor, the fat overlying it was dissected and the 
renal capsule around the tumor was incised by monopolar hook. Then cold ischemia 
was started. This was achieved by occluding the renal artery, and perfusion of 1000 
ml iced ringer lactate at 4°C at a rate of 50 ml/min through the angiocatheter. 100 ml 
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of 20% mannitol was added to each 1000 ml ringer lactate to achieve osmolality of 
430 mOsm/ml to avoid parenchymal oedema. Renal temperature was continuously 
monitored with a thermo probe residing in the parenchyma. When a parenchymal 
temperature of 25°C was reached, perfusion was reduced to maintain a steady state. 
The patient was warmed with warm air blanket (Bair Hugger, Augustine Medical 
Inc. Eden Prairie, USA), and his temperature was continuously monitored. Tumor 
excision was performed in a bloodless field using scissors with no diathermy 
(Figure. 5). A biopsy was taken from the tumor bed. The tumor and the overlying fat 
were placed in separate organ bag, which were removed later. The integrity of the 
collecting system was checked by injection of methylene blue through the preplaced 
ureteric catheter. Occasionally injured large vessels in the tumor bed were clearly 
observed by jet of perfusate. Therefore, both the collecting system and the injured 
vessels could be precisely repaired by a figure of 8 sutures using 4-0 vicryl (17 mm 
needle, 1/2 C) (Figure. 6-7). The cut edges of the parenchyma were approximated by 
2-3 figure of 8 sutures over a haemostatic bolster (TapoTamb: Ethicon Sarl, 
Neuchatel, Switzerland) using 0 vicryl (36.4 mm needle) (Figure. 8). Fibrin glue 
(Baxter AG, Vienna, Austria) or a strip of a Tachocomb (Nycomed, Linz, Austria) 
was applied on the cut surface to avoid delayed bleeding. A tube drain was always 
left in place. 
 
                
Figure 5: Left kidney: Tumor resection in a bloodless field during cold ischemia. In 
the background thermoprobe is seen residing in the renal parenchyma 
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A.                                                             B. 
Figure 6. Left kidney. A, entry to collecting system is evidenced by methylene blue 
leakage. B, suture repair of collecting system with jet of perfusate issuing from cut 
vessel on tumor bed. 
 
 
         
Figure 7.  Suture repair of left kidney (K) renal vein (V) in complete bloodless field 
after resection of centrally located tumor. R, renal parenchyma resection margin. 
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Figure 8. Left kidney after complete parenchymal repair with sutures over 
hemostatic bolster. 
 
3.1.3. Discussion  
 
Laparoscopic partial nephrectomy with our technique could be performed 
successfully in all patients with no conversion. The mean intraoperative blood loss 
was 145 ml (30 – 650). In 2 patients we had high blood loss. In one of them it was 
due to insufficient balloon occlusion and in the other one because of intermittent 
failure of the perfusion pump, which resulted in venous backflow from the injured 
renal vein. Only one patient required intraoperative blood transfusion. Mean total 
ischemia time was 41 minutes. (27 - 101 min.). Entry to the collecting system 
happened in 7 patients and was repaired intraoperatively. Repair of the renal vein, 
segmental vein and artery was done in 2 patients, in whom the tumors were centrally 
located very close to the hilum. Mean amount of perfusate was 1,600 ml (1,150-
2,800). Mean decrease of body temperature during cold perfusion was 0.66°C (0.5-
1.1). Mean operative time was 176 minutes (135-220). Urethral and ureteric 
catheters were removed on the second postoperative day. Drainage was removed 
when its output was less than 50ml/24hours. Mean hospital stay was 9.4 days (7- 14 
days). Bleeding occurred in one case in the first postoperative day due to 
 28 
parenchymal tear from the sutures. This was managed laparoscopically by bipolar 
coagulation and application of a strip of Tachocomb (Nycomed, Linz, Austria). No 
urinary fistula or urinoma were encountered. The histopathological examination 
revealed RCC in 13 patients, angiomyolipoma in 2, and pyelonephretic renal tissue 
in another 2. The resection margins were negative in 14 patients. In one patient, 
negative margin was not described where the tumor was in direct contact with the 
renal vein. During resection the vein was entered and repaired. 
 
Postoperative renal function was evaluated in 8 patients. In 5 patients the reduction 
in renal function was 1%, 1%, 2%, 3%, and 8%, respectively by renal scintigraphy 
(DMSA). In the other 3 patients, CT scan showed undisturbed perfusion of the renal 
parenchyma. We concluded that the reduction in renal function was most probably 
attributed to reduction in the total renal volume after wedge resection. 
 
Cold arterial perfusion is an old method, which however is not remembered anymore 
nowadays. It was developed for open renal stone surgery by Marberger and 
colleagues in 1978 (Marberger et al. 1978)
44
 and it is still used by vascular surgeons 
to protect the kidney during the repair of complicated thoracoabdominal aneurysms 
(Morishita et al 1999)
45
. For these purposes, it has been proved to be effective and 
safe. Since external renal cooling by slushed ice is easier to apply, this technique is 
not used anymore for open kidney surgery.  
 
Laparoscopic NSS without renal ischemia is feasible and can be achieved by step-
by-step resection and hemostasis without ischemia (Janethschek et al 1998; Jeschke 
et al. 2001)
43,46
. However, this technique has its drawbacks. It is restricted to small 
tumors (2cm or less) in a favorable peripheral location. Hemostasis is slow and 
tedious. The cut surface is continuously covered with blood and burned by the 
extensive use of monopolar and bipolar coagulation, therefore distinction between 
tumor and normal renal tissue is very difficult. This may compromise complete 
tumor resection. Necrosis urinary fistula from the use of diathermy close to the 
collecting system was also encountered. These were the reasons for us to replace this 
technique by partial nephrectomy in ischemia.  
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During ischemia, the tissue is cut sharply in a bloodless field, avoiding the use of 
diathermy. Normal renal tissue and tumor can be discriminated very precisely, so 
that complete tumor resection can be continuously monitored. As in open surgery, 
hemostasis relies on suturing the cut edges of the parenchyma on bolsters of 
haemostatic materials (Gill et al. 2002)
18
. A major restriction for this technique is the 
time, as renal damage is expected if the ischemia time is longer than 30 minutes. 
Therefore cooling of the kidney as in open surgery is required if ischemia time is 
anticipated to last more than 30 minutes as in larger tumors and tumors in 
unfavorable sites. In addition unexpected problems during surgery may extend the 
time of operation.  
 
In animal model, cooling has been performed by injecting cold fluid in the collecting 
system (Landman et al. 2002)
47
. Because of the relatively small surface of the 
collecting system and its central location within the kidney, parenchymal cooling 
may be insufficient. Contrary, cold arterial perfusion will directly cool the 
parenchyma, which is well perfused. Because of the large surface area of the arterio-
venous system in the kidney, efficient heat exchange can be achieved. External renal 
cooling with slushed ice during laparoscopic wedge resection has been described in 
one patient (Gill et al. 2002)
18
. This may become an alternative method for cold 
ischemia in NSS.  
 
During laparoscopic wedge resection, cold arterial perfusion has the advantage that 
the laparoscopic procedure itself is not rendered more complicated than resection 
without ischemia since all necessary maneuvers are performed prior to surgery. 
Resection of the tumor and parenchymal repair can be done in a clear bloodless field 
at leisure of time. During our initial experience we realized another advantage of our 
technique. Since the whole renal vasculature from the renal artery to the vein is 
completely filled with perfusate, repair of arterial and venous lesions becomes 
feasible in a completely bloodless field. In addition jets of perfusate will help in 
recognition of the exact site of the vascular injury. In two complicated centrally 
located tumors, vascular lesions had to be repaired after removal of the tumor. These 
procedures would certainly not have been possible without ischemia and cooling.  
 
 30 
In our series we didn’t encounter any problem regarding the renal function or the 
amount of perfusate used. This is probably because all the patients were with a 
normal contralateral kidney and diuresis was induced prior, during and after 
ischemia. However in a solitary kidney, one should be aware of the risk of volume 
overload resulting from the non-excretion of the perfusate during temporary renal 
ischemia. In this case excretion of the perfusate will depend on the fast recovery of 
the kidney after ischemia.  
 
3.1.4. Conclusion  
 
Our initial experience of incorporating cold ischemia via arterial perfusion to 
laparoscopic partial nephrectomy shows the feasibility and safety of this technique. 
Injury to the arterial system has been observed neither in the literature nor in our 
limited experience. This approach allows the duplication of the principles of the 
open surgery and makes laparoscopic NSS for RCC and complex renal pathology 
safe and reliable. It also allows for vascular repair during surgery of difficult central 
tumors. We believe that our technique will make laparoscopic NSS safer for the less 
experienced laparoscopist and will also increase the scope of indications for the 
experienced one.  
 
 
3.2. LAPAROSCOPIC PARTIAL NEPHRECTOMY IN WARM ISCHEMIA  
 
3.2.1. Introduction 
 
Partial nephrectomy (PN) has become a standard of care for treatment of small renal 
masses. Hilar occlusion is commonly performed for a precise tumour resection and 
renal reconstruction. The above surgical manoeuvre results in warm ischemia (WI) 
of the remaining renal tissue and has been associated with ischemic-reperfusion 
injury (RI) to the organ. Current evidence showed that the length of the warm 
ischemia time (WIT) and the subsequent reperfusion injury may result in permanent 
renal damage (Becker et al 2009; Simmons et al 2008)
48-49
. Moreover, the resection 
of the renal tumour and the suturing of the parenchyma resulted in additional 
reduction of the functional renal tissue (Simmons et al 2012; Song et al 2011)
50-51
. 
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Thus, two mechanisms of renal function damage during PN could be proposed. 
Nevertheless, the importance of the mechanisms for the decline of the postoperative 
renal function has not been investigated. The current prospective study evaluated the 
split renal function and elucidated the role of renal parenchymal loss in patients with 
small renal mass who were treated by LPN with WI. 
 
3.2.2. Patients and methods 
 
Small renal masses have been treated by LPN at our institutions since 2005. Thirty 
five patients were enrolled in a prospective pilot study. Regional research ethics 
committee approval was received and informed consent was obtained from all 
patients. The procedures were performed by two experienced laparoscopists. The 
exact location and dimensions of the tumour was identified by three-dimensional CT 
scan prior to the operation. Only patients with a single exophytic mass of ≤ 4 cm in 
diameter located in either lower or upper pole of the kidney with normal 
contralateral kidney were enrolled. 
All operations were performed by laparoscopic transperitoneal approach with en-
bloc hilar occlusion using a Rumel tourniquet. Two minutes before hilar occlusion, 
0.5 gr/kg of 20% mannitol was infused. The surgical technique has been previously 
described (Spaliviero and Gill, 2007)
52
. Cold scissors were used for tumour 
resection. Running sutures of 3/0 Vicryl were applied for collecting system closure 
and haemostasis. In all cases, the parenchymal defect was filled with one or two 
rolled Surgicel bolsters. Parenchymal reconstruction was achieved by running 0 
Vicryl sutures secured at each parenchymal exit by a Hem-o-lok clip. The renal 
pedicle was released only after tumour excision and completion of renorrhaphy. At 
the time of hilar tourniquet release, 0.5 mg/kg of Furosemide injection was 
administered. 
After extraction of the specimen, the surrounding fat tissues were detached and 
weight of the remaining resected mass was measured. The kidney was placed in its 
anatomic position and the Gerota's fascia was closed. 
The recorded parameters included the time for tumour resection, calyceal closure, 
haemostatic sutures and the total WIT.  
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Serum creatinine (sCr) was recorded and estimated glomerular filtration rate (eGFR) 
was calculated using chronic kidney disease epidemiology collaboration (CKD-EPI) 
equation (Levey et al. 2009)
53
. 
The above measurements were performed preoperatively (baseline), 5-6 hours after 
the surgery, on the 1
st
, 3
rd
 and 7
th
 postoperative days and at the end of 1
st
, 3
rd
, 6
th
, and 
12
th
 postoperative months. 
 
In this study, in addition, 15 randomized patients treated with laparoscopic radical 
nephrectomy (LRN) were examined as a control group for our laboratory outcomes 
and all the above parameters were registered in this group. 
 
3.2.3. Renal scintigraphy 
 
In order to distinguish the impact of parenchymal loss from WI effect on the 
operated kidney, we planned a novel method of investigation with renal scan as 
follow. All patients in LPN group underwent 99m Technetium-Dimercaptosuccinic 
Acid (99mTc-DMSA) renal scintigraphy for the determination of split renal function 
preoperatively and at the end of 1
st
, 3
rd
, 6
th
, and 12
th
 postoperative months. 
99mTc-DMSA isotope is a static renal agent and allows accurate calculation of 
differential renal function (DRF) (Kibar et al. 2003)
54
. Since 99mTc-DMSA scan 
provides relative functional percentage of the two kidneys and the contralateral 
kidney served as a control for comparison after LPN, we selected patients with 
solitary small polar mass (T1a), otherwise normal ipsilateral kidney, and normal 
contralateral kidney. Such selections have resulted in a young cohort of patients with 
mean age of 50.5 ± 11.9 years old in our study. 
 
3.2.4. Assessment of total and partial differential renal function: A novel 
approach. 
 
Before the operation, all patients underwent radionuclide isotope examination 
performed by 99mTc-DMSA. Renal scans were performed in supine position. 
Individual kidney uptake and differential renal function (DRF) percentage of left-to-
right kidneys were determined by the Patlak-Rutland method (Rutland, 1996)
55
. The 
region of interest (ROI) of each kidney was determined with the use of an automated 
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computer program drawing the ROI around the whole kidney. For processing 
purposes, all isotope results were saved in a computer program. This assessment 
which is a customary method of evaluating a static renal scan was called a “Total-
DRF” (T-DRF) in our study (Figure 9A). 
By this means, in the tumorous kidney, the postoperative decline in percentage ratio, 
reflecting decrease in renal function, was considered as a consequence of both 
factors: 1). IR injury caused by length of WIT. 2). The kidney parenchymal volume 
reduction caused by removal of the tumour, and excision and suturing of the 
surrounding healthy tissues.  
In an attempt to distinguish the impact of each of these two factors, we introduced a 
novel method which is referred as “Partial-DRF” (P-DRF). For this reason, in the 
preoperative renal scans, the exact location of the tumour was determined and only 
small polar masses (either upper or lower pole mass) were selected for the study. In 
the tumorous kidney, a region in the tumour-free pole was selected and manually a 
ROI was drawn in that pole. Identical ROI was selected in the same pole of the 
contralateral kidney (Figure 9B). The same ROI drawing was used in all follow-up 
studies of a given patient. Accordingly, P-DRF which reflects DRF of the intact pole 
of the operated kidney, which is affected only by the IR injury, was compared with 
the same pole on the contralateral kidney. The same processing was applied for all 
patients in all isotope scan examinations. As a result, in the postoperative isotope 
scans, with the P-DRF, we could compare an intact part of the operated kidney 
which was impacted by WI but not affected by parenchymal volume reduction with 
an identical segment of the normal contralateral kidney. 
Any postoperative decline in the P-DRF of the operated kidney was considered as 
the renal functional loss resulted from IR injury only.  
All renal isotope tests were evaluated and reported by same specialist doctor in 
nuclear medicine. 
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Figure 9: Renal scintigraphy is shown with an imaginary tumour in the lower pole 
of one kidney (red circle). A: The ROI is selected (purple line) to demonstrate and 
compare the T-DRF of both kidneys. B: The ROI is selected in the nontumorous pole 
of the involved kidney and compared with the same ROI in the contralateral kidney. 
 
3.2.5. Patient selection and statistical evaluations.  
 
Any factor which could unpredictably influence on the WI consequence or the renal 
function outcome was excluded from the statistical assessments. Accordingly, one 
patient was excluded due to conversion to open partial nephrectomy assuming that 
absence of pneumopreritoneum may give diverse renal functional outcome. One 
patient was excluded due to continuous moderate bleeding from the resected site 
during WI time. In this patient, we presume that WI was insufficient due to incessant 
blood supply to the kidney. In one patient with two accessory renal arteries, we had to 
clip one of the arteries for safe resection. In this case, we suppose that some renal 
function deterioration may be as a result of arterial clipping so this patient was not 
included for evaluation. In one case, five days after the operation, selective segmental 
arterial embolization of the operated kidney was applied due to arteriovenous shunt. 
This patient was also excluded owing to impact of embolization on the renal function 
outcome. Three patients were disqualified for statistical analysis since they missed 
more than one cycle of post operative follow-ups. Consequently, 28 patients were 
enrolled in the final statistical analysis. Demographics of the 28 patients which were 
included for analysis, and results of the operations are described in Table 4. 
 
 35 
Table 4 – Patient’s demographics and operation results of LPN 
Number of enrolled patients 35  
Reasons for patient exclusion (number of patients) : 
 - Conversion to open partial nephrectomy 
 - Continuos moderate bleeding from the resected site during WIT 
 - One of two accessory arteries were clipped for safe resection 
 - Early postoperative bleeding and selective arterial embolization 
 - Missed more than one follow-up appointment 
 
1 
1 
1 
1 
3 
Number of patients included in statistical analysis 28 
Male / female ratio 16 / 12 
Patient’s age (years) 50.5 ± 11.9 (range: 23-74) 
Body mass index 27.6 ± 4.3 (range: 19.7-39) 
Right / left ratio 12 / 16 
Tumor greatest dimension (mm) by CT Scan 26.4 ± 6.4 (range: 18-40) 
PADUA classification of tumors 7 (range: 6-10) 
Surgery indication: 
 - Relative 
 - Elective 
 - Absolute 
 
17 
11 
0 
Operative time (min) 145 ± 35 (range: 95-245) 
Time used for tumor resection (min) 4.8 ± 1.5 (range: 2.5-10) 
Time used for internal sutures (min) 9.6 ± 3.5 (range: 5-18) 
Warm ischemia time (min) 22 ± 5.3 (range: 12-32) 
Weight of the resected specimen (gm) 18 ± 9.1 (range: 6-40) 
Histopathology results: 
 - RCC, Conventional type 
 - RCC, Chromophobe type 
 - RCC, Papillary type 
 - Oncocytoma 
 - Angiomyolipoma 
 
19 (68%) 
2   (7%) 
4   (14%) 
2   (7%) 
1   (4%) 
Positive Surgical Margins None 
PADUA: Preoperative aspects and dimensions used for an anatomical classification 
of renal tumours ; RCC : Renal cell carcinoma; WIT: Warm ischemia time 
 
Statistical evaluations: The IBM SPSS version 20 (IBM Corp., Armonk, NY, 
USA) was used for the calculations and statistical analysis. ANOVA and Pearson 
product-moment correlation were calculated as deemed necessary. A p-value < 0.05 
was considered statistically significant. 
For further confirmation, a linear correlation coefficient was calculated for the 
assessment of a possible correlation of the T-DRF decline to the WIT in the operated 
kidney and to the mass of the resected specimen. 
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3.2.6. Patients operated with laparoscopic radical nephrectomy 
 
In 15 patients with LRN selected for control group, the mean age was 61 ± 12 years 
(range: 41-78). The male to female ratio was 11/4, and right to left involved kidney 
ratio was 12/3. Their mean BMI was 29.7 ± 5.4 (range: 21.6-38.6), and the mean 
operative time was 153 minutes (range: 100-220). The mean age, BMI and the mean 
operative time were slightly higher than in the group of LPN.  
 
3.2.7. Results  
 
Twenty eight patients with small renal mass successfully underwent LPN and 
completed one year follow up according to our protocol. Operation data and 
histopathology results are summarized in Table 4. During operation, after hilar 
unclamping, in six patients we observed mild bleeding from the resected margin, 
which were resolved within 2-3 minutes by increasing pneumopreitoneum or 
application of Surgicel. We didn’t have any significant bleeding, necessitate hilar re-
occlusion. In our selected patients for statistical evaluations, major intra- or 
postoperative complication was not observed.  
 
In the LPN group, the mean results of preoperative and postoperative renal function 
measured by serum creatini (sCr), estimated glomerular filtration rate (eGFR, CKD-
EPI equation) as described by Levey and collegaues (Levey et al. 2009)
53
 and total 
differential renal function (T-DRF) as well as partial differential renal function (P-
DRF) are summarized in Table 5.  
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Table 5. Mean estimations of kidney function before and after LPN surgery 
 
 
Investigated parameter 
and normal ranges 
Pre- op 
(baseline) 
1 day 
post-op 
3 days 
post- op 
7 days 
post- op 
1 month 
post- op 
3 months 
post- op 
6 months 
post- op 
12 months 
post- op 
Mean of all 
post-op results 
after day 1 
Serum Creatinine 
(62-106 µmol/l)  
71 ± 14 
(44-94) 
86 ± 22 
(43-120) 
82 ± 20 
(42-124) 
82 ± 16 
(50-112) 
80 ± 16 
(43-103) 
79 ± 17 
(47-108) 
80 ± 17 
(40-98) 
82 ± 16 
(50-111) 
81 
(14% ↑) 
eGFR (CKD-EPI) 
(> 90 mL/min/1.73m
2)
 
97 ± 17 
(55-122) 
81 ± 21 
(44-114) 
87 ± 20 
(55-117) 
85 ± 18 
(60-106) 
87 ± 18 
(49-114) 
90 ± 21 
(48-124) 
87 ± 20 
(54-120) 
86 ± 20 
(48-116) 
87 
(10% ↓) 
T-DRF of the involved 
kidney (%) 
49 ± 4 
(43-58) 
Not done Not done Not done 
42 ± 7 
(24-52) 
42 ± 7 
(25-54) 
41 ± 7 
(25-52) 
41 ± 7 
(24-51) 
42 
(7% ↓) 
P-DRF of non-tumorous 
pole of involved kidney 
(%) 
50 ± 4 
(44-59) Not done Not done Not done 
47 ± 6 
(37-57) 
48 ± 5 
(37-55) 
46 ± 4 
(35-52) 
47 ± 4 
(38-54) 
47 
(3% ↓) 
 
Pre-Op: Preoperative; Post-op: Postoperative; eGFR: Estimated glomerular filtration rate; CKD-EPI: Chronic kidney disease 
epidemiology collaboration; T-DRF: Total differential renal function; P-DRF: Partial differential renal function 
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3.2.8. Evaluation of the renal function based on serum creatinine.  
 
The detailed mean values of these tests are shown in Table 5 for LPN and Figure 10 
for both LPN and LRN patients. In Figure 10, the preoperative (time point 1) mean 
values of serum creatinine as well as the mean values at the eight postoperative 
check points is shown for both LPN and LRN groups. The two groups were 
compared taking into consideration that in LRN group we had elder population (61 ± 
12 years vs. 50.5 ± 11.9 years, p-value = 0.008), more male to female ratio (73% vs. 
57%) and higher body mass index (BMI) (29.7 ± 5.4 vs. 27.6 ± 4.3, p-value = 0.18). 
These data may explain the higher baseline (84 umol/l) serum creatinine in the LRN 
group. It was a strong increase of serum creatinine level immediately after LRN with 
a peak on the 3
rd
 post-op day. It declined slightly and remained constantly high (123 
umol/l) until the end of first postoperative year. This reflects ~ 46% rise in sCr level 
compared to the baseline in LRN patients. In contrary, in the LPN group, the serum 
creatinine level was only slightly increased from 71 umol/l to 82 umol/l (~16% 
increase) during the first three postoperative days and remained constant until the 
end of observation. 
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Figure 10: The curves show the mean preoperative (time point 1) serum creatinine 
and mean results of postoperative serum creatinin measured in patients with LRN 
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and LPN at different time intervals (point 2: 5-6 hours post-op; point 3: 1
st
 post-op 
day; point 4: 3
rd
 post-op day; point 5: 7
th
 post-op day; point 6: 1
st
 post-op month; 
point 7: 3
rd
 post-op month; point 8: 6
th
 post-op month; point 9: 12
th
 post-op month)   
 
 
3.2.9. Evaluation of the renal function based on estimated GFR.  
 
As shown in Table 5 and Figure 11, the mean preoperative or baseline eGFR of 
patients treated with LPN was 97 ± 17 (range: 55-122) which decreased to 81 ± 21 
(range: 44-114) in the 1
st
 postoperative day (p-value = 0.0069). This shows a 16% 
decline in average eGFR which was the largest postoperative drop within one year 
of follow up. Conventionally, we call it “transient-state” of kidney function 
deterioration. In the 3
rd
 postoperative day, we observed a 7% recovery in the average 
eGFR comparing to the 1
st
 day. Although, due to the large deviations in the values, 
this tendency toward recovery was statistically insignificant (p-value = 0.3821). 
From the 3
rd
 postoperative day to end of the study in 12
th
 month, the average eGFR 
remained roughly the same in both groups. In these time points of LPN group, 
comparing the lowest with the highest values, which were in the 7
th
 postoperative 
day and 3
rd 
month respectively, showed insignificant alteration in the eGFR (p-value 
= 0.4483) (Figure 12). Accordingly, for simplicity, average of all postoperative 
eGFR mean values after the transient-state (after the 1
st
 day) were calculated and 
considered as the “steady-state” of renal function deterioration. This was 87 
ml/min/1.73 m
2
 in LPN patients which demonstrates ~10% decrease in renal 
function comparing to the baseline (p-value = 0.0757). 
As shown in figure 13, the eGFR was lower for patients treated with LRN and 
showed a decrease during the first three postoperative days and thereafter remained 
at the same level. By this comparison, the difference in clinical parameter between 
the two groups as indicated above also should be taken into account. 
It is worth to highlight that in the LRN control group, the average decline in the 
“steady state” of the kidney function was ~ 40% (81.34 declined to 48.36 
ml/min/1.73 m2). 
In a simple explanation, we can conclude that, by removal of one whole kidney, 
nearly 40% of global kidney function declines, and by removal (resection) of one 
part of a kidney, nearly 10% of the global kidney function decreases. Accordingly, 
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parenchymal volume reduction after partial nephrectomy has a very important 
impact on outcome of kidney function and this should be certainly distinguished 
from the impact of the IR injury caused by WI.    
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 Figure 11.  The graph shows the mean preoperative and postoperative eGFR values 
in the studied time intervals for the LPN patients enrolled in the statistic evaluation. 
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Figure 12. This graph shows same parameters as the previous graph (figure 11) 
excluding the baseline and the 1
st
 post-op values. It remarks the so called “steady-
state” of renal function after partial nephrectomy.  
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Figure 13. The curves show mean preoperative (time point 1) eGFR and mean 
results of postoperative eGFR measured in patients with LPN and LRN at different 
time intervals (point 2: 5-6 hours post-op; point 3: 1st post-op day; point 4: 3rd 
post-op day; point 5: 7th post-op day; point 6: 1st post-op month; point 7: 3rd post-
op month; point 8: 6th post-op month; point 9: 12th post-op month) 
 
 
3.2.10. Impact of parenchymal volume reduction on the kidney function 
 
As seen in Table 5 and Figure 14, in the LPN study group, the mean preoperative or 
baseline T-DRF of the operated kidneys was 49% which is decreased to 42% on the 
1
st
 postoperative month (p-value = 0.001). This value remained almost the same in 
the following time points. Repeated ANOVA measurements of all postoperative T-
DRF did not show any significant alteration among them (p-value > 0.6). 
Accordingly, average of all postoperative T-DRF which was 42% was considered as 
the final postoperative result. On the other hand, the mean preoperative P-DRF of 
the intact pole of the operated kidney was 50% which decreased to 47% on the 1
st
 
postoperative month (p-value = 0.0727). Average of all postoperative P-DRF was 
also 47% without any significant alteration among the time periods (p-value = > 
0.1). 
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Figure 14. The graph shows the mean decline of both P-DRF and T-DRF of the 
operated kidney (LPN) in the studied time intervals.  
 
Linear correlation coefficient was used to compare relationship of the T-DRF 
decline in the operated kidney to the mass of the resected specimen (Figure 15).  
We have also used linear correlation coefficient to compare relationship of the T-
DRF decline in the operated kidney to WIT (Figure 16). This showed a much 
stronger correlation between T-DRF decline and the resected mass comparing to the 
WI time (R2 = 0.7241 and p0.0837 respectively). 
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Figure 15. Comparing correlation of the T-DRF decline in the operated kidney to 
the mass of the resected specimen 
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Figure 16. Comparing correlation of the T-DRF decline in the operated kidney to 
WI time.  
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3.2.11. Discussion 
 
In 1950, Benjamin Abeshouse wrote “Few procedures provide the urologist with 
more satisfaction than those that preserve renal function”
56
. While Dr. Abeshouse 
may have practiced urology prior to the availability of the strong data we now 
possess, his statement rings true to this day. On this principle, NSS has taken a 
prominent position at the helm of the treatment of renal tumours. Likewise, there has 
been continual progress toward resecting less and less renal parenchyma to preserve 
more renal function without sacrificing any of oncological rules. 
There are several factors determining the postoperative renal function: A. the 
preoperative quality of renal function (underlying renal disease, limited glomerular 
function, etc.); B. the quantity of renal parenchyma remained after operation; and C. 
the warm ischemia time. The first factor can’t be modified by surgical technique; the 
second is determined by the anatomical size and location of the tumour. The warm 
ischemia time is influenced by the experience of the surgeon and the operation 
technique applied. 
 
We planned a prospective study in order to distinguish the impact of parenchymal 
loss and effect of warm ischemia on the function of operated kidney. In our study, 
99m
Tc-DMSA isotope was used which is a static renal agent and allows accurate 
calculation of DRF (Kibar et al 2003)
54
. This was measured preoperatively and 
completed in different postoperative intervals in 28 patients with solitary small polar 
renal mass and no any other abnormality in that kidney. Since 
99m
Tc-DMSA scan 
provides relative functional percentage of the two kidneys and the contralateral 
kidney served as a control for comparison after LPN, we selected patients with 
normal contralateral kidney. Such selections have resulted in a young cohort of 
patients with mean age of 50.5 ± 11.9 years old in our study. The T-DRF was 
measured in all isotope studies. Any postoperative decline in T-DRF in the operated 
kidney was considered as a result of warm ischemia and ischemia-reperfusion injury 
combined with parenchymal loss. In nearly all postoperative studies, mean decline 
of T-DRF in the operated kidney was 7%. In order to distinguish the effect of warm 
ischemia from the parenchymal loss, we introduced the so-called P-DRF in which a 
region of interest was selected on nontumorous pole of the involved kidney and it 
was compared with the same region in the contralateral kidney.  
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For this reason, we selected only patients with tumor mass of ≤ 4 cm in diameter 
which were located on either upper or lower pole of the kidney so that the region 
selected in the intact nontumorous pole of the operated kidney was not affected by 
parenchymal loss and suturing. Any postoperative functional decline in this intact 
pole of the operated kidney was considered to be as a result of warm ischemia and 
ischemia-reperfusion injury only. In our study, mean postoperative decline in the P-
DRF of the operated kidney was only 3% which was found to be statistically 
insignificant (p-value = 0.0727). In agreement with the previous studies, we believe 
that within certain time limits of warm ischemia, which was 22 ± 5.3 minutes in our 
study, the ischemia-reperfusion insult may be negligible or reversible. On the other 
hand, deliberate parenchymal loss plays a major role in kidney function 
deterioration. 
 
Warm ischemia and the IR injury to the kidney have been considered for a long time 
as the main factor related with postoperative renal function deterioration in patients 
undergoing PN under WI
30,48,57,58,59,60
. Several technically challenging techniques 
have been introduced for the reduction of WI
61,62
. Nevertheless, the impact of renal 
parenchymal mass reduction was not distinguished from the effects of WI and IR in 
the above literature. Parenchymal loss after PN occurs as a result of intentional 
tumor excision, some normal parenchyma resection and suturing. Thus, the mass or 
volume of the parenchymal loss should be considered and differentiated from IR 
injury when evaluating the renal functional outcome after PN. 
 
Few authors have studied the impact of parenchymal volume reduction on renal 
function. In a large multicenter study cohort Shikanov and colleagues (Shikanov et 
al. 2010)
63
 assessed the influence of renal ischemia on long-term global renal 
function after LPN in patients with 2 functioning kidneys. They retrospectively 
evaluated eGFR of 401 patients with median tumor size of 25 mm and normal 
contralateral kidney who underwent LPN with median warm ischemia time of 29 
minutes. Changes in early postoperative and nearly one year follow-up eGFR were 
-16% and -11%, respectively. This result is nearly identical to our findings. The 
percent change in last eGFR was worse in patients with larger tumors suggesting 
that excising a larger lesion would result in more loss of renal parenchyma. Mir and 
colleagues (Mir et al 2015)
64
 also reported that the preservation of the total renal 
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function after PN ranged between 88% and 91% which reflects approximately 10% 
loss of the renal function (similar to our finding). Mir et al also showed that a higher 
reduction of the eGFR in patients with larger tumors which could be attributed to the 
excision of a larger lesions and the consequent greater loss of renal parenchyma. 
This was documented also by Sharma and colleagues (Sharma et al 2008)
65
 in 21 
patients with solitary kidney who underwent partial nephrectomy due to small renal 
mass. Volume of the kidney was measured preoperatively and postoperatively by CT 
scan and software with an automated segmentation algorithm. An average of 15% 
parenchymal volume loss and 19.7% deterioration in kidney function were 
documented in mid-term postoperative period. They concluded that the percent of 
renal parenchymal volume loss was correlated with the percent loss in eGFR. It was 
shown that volume loss had a more direct, predictable effect on ultimate eGFR than 
ischemia time. A similar result was concluded by Simmons and colleagues 
(Simmons et al. 2012)
50
 and also Song and colleagues (Song et al. 2009)
66
. In the 
later study, Diethylenetetramine pentaacetic acid (
99m
Tc-DTPA) was used for 
accurately estimating renal clearance and measuring eGFR by the kidney. They 
measured changes in individual renal function and investigated factors determining 
the degree of functional reduction in 65 patients who underwent LPN and 52 
patients with open partial nephrectomy. In the entire cohort, renal volume reduction 
was the most significant, independent prognosticator for eGFR reduction after 
partial nephrectomy. Mir and colleagues (Mir et al. 2013)
67
 evaluated the role of 
volume preservation by introducing computed tomography volumetric analysis using 
free-hand scripting. The eGFR was measured by MAG3 in 92 patients who 
underwent partial nephrectomy. The authors revealed that the ultimate renal function 
after partial nephrectomy was primarily driven by parenchymal preservation with 
ischemia playing a secondary role as long as it was within a limited time period.  
 
Current literature has not concluded to the most important factor for the renal 
function decline after PN and the contribution of WI to the postoperative renal 
function has not been well documented
64
. Some investigators advocated that the 
parenchymal mass preservation was stronger correlated to the functional recovery in 
comparison to the WI
51,66
. 
The current prospective study aimed in distinguishing the impact of parenchymal 
loss from the WI effect on the operated kidney. The 99mTc-DMSA isotope was used 
 47 
for the purpose due to the fact that it allows accurate calculation of DRF
54
. The latter 
parameter was measured preoperatively and in different postoperative intervals in 28 
patients with solitary small polar tumours. Since 99mTc-DMSA scan provided 
relative functional percentage of the two kidneys, the contralateral kidney served as 
the control for the comparison after LPN. Consequently, only patients with normal 
contralateral kidney were selected and a young patient population with mean age of 
50.5 ± 11.9 years was eventually included in the study. Any postoperative decline in 
the T-DRF of the operated kidney was considered as a result of WI and WI 
combined with parenchymal loss. In nearly all postoperative studies, a mean decline 
of 7% in the T-DRF was noted. In an attempt to distinguish the effect of WI from the 
parenchymal loss, the P-DRF was introduced. A ROI was selected on the non-
tumorous pole of the involved kidney and was compared with the same ROI on the 
contralateral kidney. Any interference of the excision area to the ROI was prevented 
by including only patients with tumour mass of ≤ 4 cm in diameter located on either 
upper or lower pole of the kidney. Any postoperative functional decline in this intact 
pole of the operated kidney was considered to be as a result of WI only. The mean 
postoperative decline in the P-DRF of the operated kidney was only 3% which was 
found to be statistically insignificant (p-value = 0.072). In agreement with the 
previous studies
68
, it could be suggested that WI may result in negligible or 
reversible renal damage within certain time limits of WIT such as a mean WIT of 
the current study. In addition, the parenchymal loss seemed to play a more important 
role in kidney function deterioration than WI. Considering the above, it could be 
advocated that the LPN surgical technique could probably focus on the precise 
tumour excision and suturing rather than to the minimization of WIT. Nevertheless, 
additional studies are necessary for the confirmation of the above hypothesis. 
 
Limitations of this study include the reliance on DRF and the use of the non-
operated kidney as a stable reference unit before and after the surgery. Any 
postoperative compensatory hypertrophy of the contralateral kidney may result in a 
false outcome of DRF. Takagi et al.
69
 showed that the compensatory hypertrophy of 
the contralateral kidney after PN remained rather limited and less than 2.3% in most 
cases. They concluded that the larger the excised volume of the kidney, the more 
hypertrophy of the contralateral kidney was expected. The median tumour diameter 
of the latter study was 3.5 cm and probably resulted in higher volume loss in 
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comparison to our series (median of 2.6 cm). Hence, we assume that the 
compensatory hypertrophy may have been negligible in our study.  
Another limitation of our study was the lack of stratification of the results according 
to the length of the WIT or the tumour size. The parenchymal volume was never 
measured and the current study could not provide information regarding the pre-and 
postoperative changes in the volume of the renal parenchyma. Nevertheless, the 
changes in the contour of the operated kidney may influence measurements of the 
renal volume and the selection of ROIs out of the excision field for measurements 
probably allowed for more reliable results. Moreover, the use of CT scans for the 
evaluation of renal volume would expose the patient in additional radiation without 
providing evidence that would significantly influence the results of the study. 
 
 
3.2.12. Conclusion 
 
In LPN, the parenchymal loss caused by the resection of the tumor and the 
suturing of the surrounding normal tissues resulted in kidney function 
deterioration which should be distinguished from WI effects. An average WIT of 
22 minutes for a mean tumor diameter of 2.6 cm resulted in a 7% kidney function 
decline. 4% could be attributed to the parenchymal loss and 3% to WI. 
 
The ultimate renal function after partial nephrectomy is primarily driven by 
parenchymal preservation with ischemia playing a secondary role as long as it is 
within a limited time period. One of the major implications of our study is that 
creating a bloodless filed by clamping the renal pedicle within certain time limits, 
and consequently precision of excision and renorrhaphy, should be a primary 
objective during any partial nephrectomy. This may result in more kidney function 
preservation than putting all efforts to decrease WI time to zero while accepting all 
potential complications. 
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3.3. TECHNICAL MODIFICATIONS OF LAPAROSCOPIC SURGERY   
3.3.1. Laparoscopic partial adrenalectomy for recurrent pheochromocytoma 
In 1998, we performed a transperitoneal laparoscopic bilateral partial adrenalectomy 
in an 8-year-old boy with symptomatic familial pheochromocytoma, as a 
manifestation of von Hippel-Lindau disease (VHL) (Radmayr et al. 2000)
70
.
 
The 
symptoms recurred 53 months later, starting with hypertension, tachycardia and 
headache. The 24-hour urinary excretion of catecholamines was elevated. MRI 
revealed a 2.5 cm mass on the right adrenal remnant. After preoperative medications 
with phenoxybenzamine and propranolol, we performed the second laparoscopic 
transperitoneal partial adrenalectomy (Nambirijan et al. 2004)
71
. The previous port 
sites were used for placement of 3 trocars. Only the fourth trocar (5 mm) was 
inserted through an additional incision. The only observed intraperitoneal adhesion 
was at the inferior surface of the liver, which was fixed to the site of adrenal gland. 
These adhesions were removed easily to approach the tumor. Intraoperative color 
Doppler ultrasound was used to delineate the tumor. Considering that the tumor was 
embedded to a great extent in the adrenal gland, the procedure proved to be 
challenging. Dissection and hemostasis were achieved using monopolar scissors and 
bipolar coagulation forceps. The vein from the tumour could be isolated and 
transected preserving the adrenal vein. The tumour was removed completely sparing 
the normal adrenal tissue. To avoid delayed bleeding, the cut surface was sealed 
with fibrin glue. Operative time was 120 minutes. The blood loss was minimal and 
drainage wasn’t needed. Postoperative course was uneventful. Histopathological 
examination confirmed the diagnosis of pheochromocytoma. During follow-up, 
blood pressure and catecholamine values returned to normal and no residual tumor 
was observed. 
   
    
 
Patients with VHL, as well as multiple endocrine neoplasia (MEN) type 2 disease, 
are predisposed to recurrent bilateral adrenal pheochromocytoma. Partial 
adrenalectomy is considered to be the first choice of treatment in these patients in 
order to avoid a life-long steroid replacement therapy. In addition, in children 
preserving the adrenocortical function is essential for normal child growth. The high 
possibility of recurrence and also predisposition to other intraabdominal pathologies, 
such as renal cell carcinoma and pancreatic islet cell tumors in VHL may necessitate 
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repeat surgical procedures. Therefore, any surgical procedure performed in these 
patients should be as minimal as possible. Our experience with laparoscopy has 
given rise to strong arguments over open surgery in dealing with the above–
mentioned diseases. These arguments are based on advantages, which could be 
summarized as follows: 1. Minimal procedure, 2. Lower morbidity, 3. Less adhesion 
formation
, 
4. Much easier repeat operation for recurrence(s). By this technique, not 
only the recurrent tumour could be removed successfully but also the unaffected 
adrenal gland was preserved for the second time.  
 
3.3.2. New tool for laparoscopic antegrade ureteral stenting in repair of 
circumcaval ureter and pyeloplasty operations. 
 
Circumcaval ureter (CU) is a rare congenital anomaly of the inferior vena cava 
(IVC). It forms as a result of posterior cardinal vein persisting as the renal segment 
of the IVC during development. Because the posterior cardinal vein is located 
ventral to the ureter, the ureter will become entrapped behind the vein. Extrinsic 
compression or functional loss of the retrocaval ureteral segment may lead to 
ureteral obstruction and hydronephrosis and subsequently to deterioration of kidney 
function. Correction of such anomaly is recommended in specific cases. The 
pathogenesis of the disease and also the indication of the operation are nearly similar 
to that of uretero-pelvic junction (UPJ) stenosis. By development and progress of 
laparoscopic technology, laparoscopic approach is considered as the standard of care 
for such operation. One of the challenging and time-consuming parts of the 
laparoscopic approach is intraoperative antegrade ureteral stenting. Accordingly, 
several different methods have been studied and recommended for this purpose.  
 
We have developed a new method for intraoperative antegrade ureteral stenting 
(Bagheri et al. 2009)
72
. The same instrument can be used in any type of laparoscopic 
ureteric operations necessitating ureteral stenting. We have applied the new 
technique for laparoscopic transperitoneal repair with transection and reanastomosis 
of the ureter anterior to the IVC in patients with circumcaval ureters and in several 
laparoscopic pyeloplasy and ureterotomy cases. 
In one of the patients with circumcaval ureter, only a mild pelvic dilatation with 
relatively slight ureteric narrowing was noticed. Therefore, the retrocaval ureteral 
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segment was preserved and the ureter vas transected at its distal dilated part lateral to 
the IVC. The lower ureteral segment, together with the double coil stent, was 
transpositioned to the front and lateral of the IVC. The ureteral stump had a normal 
appearance and the patency of its lumen was confirmed by easy passage of an 8F 
ureteral catheter. Spatulated end-to-end uretero-ureteral anastomosis was performed 
using interrupted 4-0 Vicryl sutures. 
In two patients, the rectrocaval segment especially the ascending course appeared to 
be narrowed and aperistaltic. In these cases the ureter was transected medially to the 
IVC to access the retrocaval segment. The upper stump had a tortuous appearance 
with very narrow lumen. With peristaltic movements of the pelvis, urine jet was not 
seen. Therefore that ureteral segment was resected until a normal ureteric lumen and 
urine flow were visible.  
For stenting, we attempted to avoid any retrograde procedure. We applied antegrade 
stenting using a ureteral stenting cannula, which was developed by our group and 
used routinely in laparoscopic pyeloplastic operation in our institute (Figure 17).  
We developed two sets of ureteric stenting cannula which can be used for 
intraoperative antegrade ureteric stenting. Each cannula has a length of 28cm to be 
long enough to pass through the standard laparoscopic trocars and easily reach to the 
ureteric stump. It is 3mm in diameter so can be easily inserted into any standard 
trocar or directly into the abdomen by a small percutaneosu puncture. The lumen of 
the cannulas can easily accept stents of up to 7 French. 
The cannula in the upper portion of the picture has a mild curvature at the tip. This 
can be inserted through any standard laparoscopic trocar. The tip of the cannula can 
be directed to the lower ureteric stump to facilitate insertion of the stent or guidewire 
into the ureter. The other two parts form a separate kit. The one with a sharp straight 
tip works as a trocar. It is inserted into the straight cannula for percutaneous 
puncture from any site of the abdomen. After insertion into the abdomen, the inner 
trocar can be removed and the cannula can be used for stenting. At the top of each 
cannula, appropriate sealing cap can be used for insertion of stent and pusher or a 
guidewire without any leakage of CO2. After insertion of the stent into the distal 
ureteric stump, the cannula can be removed. After the first few anastomotic sutures, 
the upper part of the stent can be pushed into the upper ureteric stump or renal 
pelvis. 
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Based on our experience, we recommend intraoperative antegrade ureteral stenting, 
using the stenting cannula, which is fast, safe and easy to apply and additional 
transureteral retrograde procedure can be avoided. Using antegrade ureteral stenting 
has the advantage of having a dilated renal pelvis and intact upper ureter during the 
surgery. These would provide a better preparation of the ureter and renal pelvis and 
also gives a more accurate evaluation of the narrowed ureteral segment. 
 
 
 
Figure 17. Two types of ureteral stenting cannula (28 cm long with 3-mm diameter) 
were used for intraoperative ante-grade ureteral stenting. Cannula with mild 
curvature at tip, which can be inserted through any trocar with diameter 10 mm 
(upper). Ureteral stenting cannula formed of sharp, straight-tip trocar and cannula, 
which can be inserted into abdomen from any direction (lower). At top of each 
cannula is appropriate sealing cap used for insertion of double coil stent and its 
pusher.  
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3.3.3. Ligation of a wide renal vein during laparoscopic nephrectomy: an effective 
method 
 
Laparoscopic nephrectomy has been refined to a point that is now considered as a 
first option for radical nephrectomy with excellent results. The crucial step during 
laparoscopic nephrectomy is the dissection and control of renal pedicle. Application 
of the endovascular gastrointestinal anastomosis (GIA) stapler has been a standard 
procedure to control renal vein during laparoscopic nephrectomy. The significant 
complication due to device malfunctioning has led several surgeons to find another 
secure method for renal vein ligation. Accordingly, the so called Hem-o-lok clips 
were introduced. However, some renal veins may be so wide that cannot be 
occluded safely by even the largest available clip. This fact inspired us to find a 
simple, secure and cost-effective technique to ligate wide renal veins. 
 
After renal pedicle dissection, the renal artery is occluded with Hem-o-lok clips and 
divided when appropriate. A right angle dissector is passed posterior to the renal 
vein. A 2-zero 70 cm monofilament suture is fed to the dissector, which is 
withdrawn and pulled out. The other end of the suture is also grasped and drawn out 
through the same trocar, so that the suture is placed around the vein. Extracorporally 
one end of the suture is inserted into the convex side of a specially designed, round 
eyed knot pusher (Figure 18). It is then grasped by a mosquito and fixed under 
minimal tension by the assistant in the line of the trocar, while ensuring that there is 
no kinking or twisting in whole length of the thread. The knot pusher is held by one 
hand and the free end of the suture is held with the other hand to form a loop around 
the fixed part, as in open surgery. By maintaining minimal tension on each end of 
the thread, the loop is gently pushed down by the knot pusher to the level of the 
renal vein and then slightly tightened. This maneuver can be repeated 3 to 5 times to 
shrivel the vein. The whole procedure requires about 2 minutes and it can be easily 
mastered even by an inexperienced laparoscopist. 
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Figure 18. Knot pusher with closed eye and curved tip used to push down standard 
surgical knot through a 10 mm trocar. 
 
This rapid and simple maneuver is important to shrink a vein of any diameter to 
allow the safe application of clips. We preferred to use Hem-o-lok clips with a 
locking mechanism, which provides a strong hold on the tissue and prevents clip 
dislodgement. Although we have not experienced any dislodgement, we placed two 
10 mm clips on the central side in addition to the ligature and 1 on the peripheral 
side of the vein (Figure 19). This approach can be used to ligate the renal vein 
without any morbidity or significant increase of operative time. The combined use of 
suture tied extracorporally and clips with locking mechanism allows a safe, rapid 
secure ligation and transection of a vein of any size and may replace the 
endovascular GIA stapler, which may lead to complications. 
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Figre 19. A. right angle clamp is passed behind renal vein and fed with suture. B. 
renal vein is shriveled by knots tied extracorporeally. C. vein is clipped with Hem-o-
lok clips. D. renal artery and vein after clipping is completed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
4. THESIS RELATED NEW OBSERVATIONS 
 
In the past two decades, laparoscopic procedures have gained popularity among 
urologists. However, many of the laparoscopic procedures require standardization so 
all urologists can perform them safely and relatively easily. In our studies, we have 
tried to standardize some of the upper urinary tract laparoscopic techniques such as 
repair of circumcaval ureter, pyeloplasty, application of cold ischemia in partial 
nephrectomy and concerns related to warm ischemia time in nephron-sparing 
surgeries. 
 
We have observed that in pyeloplasty and any type of upper urinary tract 
reconstructive laparoscopic procedures, antegrade ureteral stenting with the ureteral 
stenting cannula which is developed by our team facilitates the antegrade stenting 
and its application is safe, easy and quick. 
 
We have proved in a prospective study that in partial nephrectomy operations, loss 
of renal parenchymal mass has an important impact on renal functional outcome. In 
nephron-sparing laparoscopic surgeries with an average warm ischemia time of 22 
minutes, we observed a 7 % kidney function decline of which, 4% contributed to the 
parenchymal loss and only 3% to the ischemia. This research and findings can be of 
beneficial in future studies to consider the following points: 
 
1. In any partial nephrectomy surgery, intentional resection and suturing of the 
renal parenchyma which results in loss of some renal mass, has a significant 
impact on kidney function. This fact should be taken into consideration and it 
should be distinguished from effects of warm ischemia time in future studies. 
2.  Probably, potentially unsafe and challenging techniques which advocate zero 
ischemia time in partial nephrectomy should not be promoted among 
urologists.  
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